Literature DB >> 21607400

Immunohistochemical study on cathepsin-B and cathepsin-d in pancreatic-cancer.

B Nakata1, H Appert, S Lei, Y Yamashita, Y Chung, M Sowa, J Myles, C Mao, J Howard.   

Abstract

Lysosomal enzymes, cathepsin B and D, have been studied in their possible relationship to the ability of malignant cells to invade and metastasize. In the current investigation, these cathepsins were detected immunohistochemically using avidin-biotin-peroxidase complex method in the pancreatic cancer cells of 21 patients. The positive rate of identification of cathepsin B and D was 43% and 81%, respectively. Cathepsin D stained more strongly than cathepsin B and the plasma membrane stained quite strongly in two instances. A correlation between the presence of cathepsin B or D in cancer cells and the degree of metastasis to lymph nodes, liver, or lung was not recognized.

Entities:  

Year:  1994        PMID: 21607400     DOI: 10.3892/or.1.3.543

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

Review 1.  Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.

Authors:  Gaetano Leto; Francesca M Tumminello; Marilena Crescimanno; Carla Flandina; Nicola Gebbia
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

2.  GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma.

Authors:  Jung Hyun Jo; Sun A Kim; Jeong Hoon Lee; Yu Rang Park; Chanyang Kim; Soo Been Park; Dawoon E Jung; Hee Seung Lee; Moon Jae Chung; Si Young Song
Journal:  BMC Cancer       Date:  2021-11-18       Impact factor: 4.430

3.  Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.

Authors:  Ujjwal M Mahajan; Elisabetta Goni; Enno Langhoff; Qi Li; Eithne Costello; William Greenhalf; Stephan Kruger; Steffen Ormanns; Christopher Halloran; Paula Ganeh; Manuela Marron; Felix Lämmerhirt; Yue Zhao; Georg Beyer; Frank-Ulrich Weiss; Matthias Sendler; Christiane J Bruns; Thomas Kohlmann; Thomas Kirchner; Jens Werner; Jan G D'Haese; Michael von Bergwelt-Baildon; Volker Heinemann; John P Neoptolemos; Markus W Büchler; Claus Belka; Stefan Boeck; Markus M Lerch; Julia Mayerle
Journal:  JNCI Cancer Spectr       Date:  2019-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.